Publications by authors named "Andreas Hoepner"

Claim this Profile
C
Corporate emissions targets and the neglect of future innovators.
Yann Robiou du Pont, Joeri Rogelj, Angel Hsu, Detlef van Vuuren, Andreas G F Hoepner

Science· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtues of impact financing: Do financial institutions benefit from considering the environmental impact on financing decisions?
Yumeng Gao, Andreas G F Hoepner

J Environ Manage· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis.
Stefanie Marti, Andreas G F Hoepner, Helly Hammer, Anke Salmen, Andrew Chan, Robert Hoepner

JAMA Netw Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data.
Anke Salmen, Stefanie Marti, Andreas G F Hoepner, Andrew Chan, Robert Hoepner

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.
Maximilian Pistor, Robert Hoepner, Andreas G F Hoepner, Yanan Lin, Simon Jung

Ther Adv Neurol Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Robert Hoepner

Ann Rheum Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study.
Andrei Miclea, Anke Salmen, Roland Wiest, Greta Zoehner, Franca Wagner, Andreas Hoepner, Robert Hoepner

Ther Adv Neurol Disord· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity.
Andrei Miclea, Marius Miclea, Maximilian Pistor, Andreas Hoepner, Andrew Chan, Robert Hoepner

Brain Behav· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis